1-2 of 2
Albert DeLeo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer

Patrick J. Schuler, Malgorzata Harasymczuk, Carmen Visus, Albert DeLeo, Sumita Trivedi, Yu Lei, Athanassios Argiris, William Gooding, Lisa H. Butterfield, Theresa L. Whiteside, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2433–2444.
https://doi.org/10.1158/1078-0432.CCR-13-2617
Published: 30 April 2014
View article titled, Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Open the PDF for Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Effect of Human Papillomavirus-16 Infection on CD8+ T-Cell Recognition of a Wild-Type Sequence p53264–272 Peptide in Patients with Squamous Cell Carcinoma of the Head and Neck

Nicky Sirianni, Patrick K. Ha, Mattias Oelke, Joseph Califano, William Gooding, William Westra, Theresa L. Whiteside, Wayne M. Koch, Jonathan P. Schneck, Albert DeLeo, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6929–6937.
https://doi.org/10.1158/1078-0432.CCR-04-0672
Published: 22 October 2004
View article titled, Effect of Human Papillomavirus-16 Infection on CD8+ T-Cell Recognition of a Wild-Type Sequence p53<sub>264–272</sub> Peptide in Patients with Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Effect of Human Papillomavirus-16 Infection on CD8+ T-Cell Recognition of a Wild-Type Sequence p53<sub>264–272</sub> Peptide in Patients with Squamous Cell Carcinoma of the Head and Neck in another window